Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

Obstructive sleep apnea and atrial fibrillation (AFib) are two conditions that share a potentially deadly link. Having one ...

Early treatment of obstructive sleep apnea may decrease the risk of Parkinson's disease, a new study published Monday finds.

The National Council on Aging reveals that about 30 million people in the US have sleep apnea, but only six million of these people have actually been diagnosed. Sleep apnea is a disorder that causes ...

FILE - A woman demonstrates how she puts on her sleep apnea breathing device at her home in Los Angeles Thursday, July 12, 2018. Tirzepatide, used to treat diabetes and obesity, can help with sleep ...

A new study found that getting CPAP treatment within the first two years of a sleep apnea diagnosis reduced the risk of ...

Anyone can develop obstructive sleep apnea (OSA), but there are certain risk factors that can make some people more susceptible to the condition than others. “Obesity, by far, is the main risk factor, ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by ...